STATE STREET CORP - TRANSLATE BIO INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$94,589,000
+74.0%
3,434,601
+4.2%
0.01%
+66.7%
Q1 2021$54,365,000
-4.5%
3,296,834
+6.8%
0.00%0.0%
Q4 2020$56,906,000
-17.3%
3,087,676
-38.9%
0.00%
-40.0%
Q3 2020$68,821,000
+100.7%
5,056,617
+164.3%
0.01%
+150.0%
Q2 2020$34,286,000
+382.2%
1,913,281
+168.3%
0.00%
+100.0%
Q1 2020$7,110,000
+40.8%
713,107
+15.0%
0.00%
Q4 2019$5,050,000
-9.5%
620,337
+10.2%
0.00%
Q3 2019$5,580,000
-11.6%
563,057
+12.7%
0.00%
Q2 2019$6,310,000
+98.1%
499,632
+59.8%
0.00%
Q1 2019$3,186,000
+200.8%
312,650
+121.4%
0.00%
Q4 2018$1,059,000
+24.4%
141,239
+66.0%
0.00%
Q3 2018$851,00085,1000.00%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,437,601$24,376,00011.53%
DAFNA Capital Management LLC 151,739$1,517,0000.62%
Bain Capital Public Equity Management, LLC 738,543$7,385,0000.52%
Baupost Group 6,491,287$62,393,0000.48%
Rock Springs Capital Management LP 1,009,179$10,092,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 276,639$2,766,0000.32%
Cormorant Asset Management, LP 454,550$4,546,0000.30%
Artal Group S.A. 600,000$6,000,0000.16%
Perceptive Advisors 500,000$5,000,0000.13%
ArrowMark Colorado Holdings LLC 367,744$3,677,0000.03%
View complete list of TRANSLATE BIO INC shareholders